Rishi Solan appointed to MedTate board of directors

London-based nutraceutical firm MedTate has appointed lawyer Rishi Solan to the company’s board of directors.Solan, an experienced finance lawyer by profession, currently practises in...

Welsh government announces £100,000 package for minor ailments training

Welsh government today announced an additional £100,000 funding package for pharmacist training.The announcement was made by Vaughan Gething, the Minister for Health and Social...

Boots’ profit falls 18% compared to previous year

The high street pharmacy chain, Boots, has reported a double-digit decline in profits for the fiscal year ending August 31, 2018.According to its 2018 annual...

Doctors, pharmacists ‘fighting for same pot of money’?

One of the biggest challenges facing community pharmacy was overcoming a conflicting relationship with the GP surgery as both were “fighting for the same...

Over 10,500 pharmacists validated for Quality Payments Scheme

The deadline for Quality Payments Scheme validation is an overnight away and 10,554 Community Pharmacy contractors have now been validated as meeting all the...

‘Stoptober’ urges people to end their bad relationship with smoking

As the annual Stoptober campaign is set to begin on October 1, Public Health England says it is encouraging to see the fastest drop...

Former Pfizer director Michelle Riddalls joins PAGB

The Proprietary Association of Great Britain (PAGB) has appointed Michelle Riddalls as its new senior director of regulatory affairs and advertising services.The former Pfizer...

Pfizer to combine off-patent drug business with Mylan: official

Pfizer announced on Monday it will combine its off-patent drug business with the generic drugmaker Mylan to create a global leader in low-cost treatment,...

McKesson’s Europe profit falls 19 per cent due to ‘challenging retail pharmacy environment in...

A challenging retail pharmacy environment in the UK has resulted in a 19 per cent drop in profit of McKesson’s European business, the company...

Stopping statin in old age raises heart disease risk

Discontinuing statins after the age of 75 years increases the risk of heart attack or stroke by around a third, according to a recent...